Literature DB >> 8372693

The lifetime prevalence of anxiety disorders in Iceland as estimated by the US National Institute of Mental Health Diagnostic Interview Schedule.

E Líndal1, J G Stefánsson.   

Abstract

The lifetime prevalence of anxiety disorders was estimated in a study of the prevalence of mental disorders in Iceland. The survey instrument was an Icelandic translation of the US National Institute of Mental Health Diagnostic Interview Schedule. The cohort consisted of one half of those born in the year 1931. The participation rate was 79.3%. The overall prevalence of anxiety disorders was 44%, with phobia effecting 18%. The most common anxiety disorder was generalized anxiety, which had a prevalence of 22% and was more common among women. Simple phobia was the most common of the phobic disorders (8.8%), followed by agoraphobia without panic (3.8%), and social phobia (3.5%). The female-male ratio for anxiety disorders was 2:1. Of those with simple phobia, the most common items were a fear of heights (41%); claustrophobia (34%); being on public transportation (31%); the fear of being in crowds and speaking in front of others (28%); of being alone (24%); of insects (22%); of bad weather (21%); and of being in water (aquaphobia) (20%). In addition, 17% of the respondents listed phobias not cited in the DSM-III, and of those with the most common phobic disorder, only 9% had consulted a physician because of this condition. Post-traumatic stress disorder was found to affect women exclusively. Comorbidity shows a mean of at least 3 additional diagnoses.

Entities:  

Mesh:

Year:  1993        PMID: 8372693     DOI: 10.1111/j.1600-0447.1993.tb03410.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  9 in total

1.  Post-traumatic stress disorder: a challenge for primary care--misunderstood and incognito.

Authors:  Larry Rosenbaum
Journal:  Br J Gen Pract       Date:  2004-02       Impact factor: 5.386

2.  Complementary medicine: implications for informed consent in general practice.

Authors:  Edzard Ernst
Journal:  Br J Gen Pract       Date:  2004-02       Impact factor: 5.386

3.  Morbidity and prescribing patterns for the middle-aged population of Scotland.

Authors:  F G Whitelaw; S L Nevin; R J Taylor; A H Watt
Journal:  Br J Gen Pract       Date:  1996-12       Impact factor: 5.386

4.  Anxiety with panic disorder linked to chromosome 9q in Iceland.

Authors:  Thorgeir E Thorgeirsson; Högni Oskarsson; Natasa Desnica; Jelena Pop Kostic; Jon G Stefansson; Halldor Kolbeinsson; Eirikur Lindal; Nikolai Gagunashvili; Michael L Frigge; Augustine Kong; Kari Stefansson; Jeffrey R Gulcher
Journal:  Am J Hum Genet       Date:  2003-04-04       Impact factor: 11.025

5.  The long-term psychological effect of fatal accidents at sea on survivors: a cross-sectional study of North-Atlantic seamen.

Authors:  E Líndal; J G Stefánsson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-02-18       Impact factor: 4.328

6.  The epidemiology of anxiety disorders: a review.

Authors:  Patrick Martin
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

7.  Reconciling disparate prevalence rates of PTSD in large samples of US male Vietnam veterans and their controls.

Authors:  William W Thompson; Irving I Gottesman; Christine Zalewski
Journal:  BMC Psychiatry       Date:  2006-05-02       Impact factor: 3.630

8.  Mice can recognise water depths and will avoid entering deep water.

Authors:  Hiroshi Ueno; Yu Takahashi; Shunsuke Suemitsu; Shinji Murakami; Naoya Kitamura; Kenta Wani; Yosuke Matsumoto; Motoi Okamoto; Takeshi Ishihara
Journal:  Transl Neurosci       Date:  2022-01-31       Impact factor: 1.757

9.  Social Phobia in an Italian region: do Italian studies show lower frequencies than community surveys conducted in other European countries?

Authors:  Mauro Giovanni Carta; Maria Carolina Hardoy; Mariangela Cadeddu; Bernardo Carpiniello; Liliana Dell'Osso; Mario Antonio Reda; Hans-Ulrich Wittchen
Journal:  BMC Psychiatry       Date:  2004-10-15       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.